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Recurrent aphthous stomatitis is a common oral mucosa 
disorder that affects 20% of the world’s population, 
characterized by recurring painful ulcers in the mouth. 
The diagnosis is primarily based on the patient’s clinical 
history. Inheritance may pose as a risk factor for the disease; 
however, the studies available are inconclusive as to the 
results attained, and they vary according to the population 
studied. Aim: to typify class I and class II HLA molecules 
and to assess how frequent these molecules are present in 
the Brazilian population with Recurrent Aphthous Stomatitis, 
compared to healthy controls. Materials and Methods: In 
this prospective, cross-sectional and investigative study, thirty 
one patients with diagnostic hypothesis of recurrent aphthous 
stomatitis were seen from February of 2004 to May of 2006. 
We obtained the DNA from those patients who matched the 
inclusion criteria and typified their HLA by PCR. Results: 
In those patients with Recurrent Minor Aphthous Stomatitis 
we found statistically significant occurrences of HLA-A33 
and HLA-B35. Conclusion: HLA-A33 and HLA-B35 may be 
associated with recurrent minor aphthous stomatitis in the 
Brazilian’s population. 
Keywords: hla antigens, aphthous stomatitis, genetics, 
stomatology.
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INTRODUCTION
Recurrent Aphthoid Stomatitis (RAS) is a common 
disease that causes the appearance of recurrent aphtha in 
the oral mucosa. Its incidence is of about 20% in the world 
population. It is more frequent in females. Despite the high 
incidence, and many studies dedicated to unveiling its 
causes, it still is very controversial regarding etiology1.
RAS is currently defined as a disease characterized 
by aphtha lesions in the oral mucosa, in a recurrent fashion 
(every fortnight or monthly), for a minimum period of one 
year, and its onset is usually in childhood or adolescence2, 
without evidences of associated systemic diseases. None-
theless, some authors state that the incidence of RAS is 
greater in the second decade of life3,4.
The disease usually has three clinical forms, based 
on the aspect and size of the ulcerations: minor, major and 
herpetiform. Recurrent Aphthoid Stomatitis Minor (RASi) 
affects 80% of the patients with RAS, and it is characterized 
by a shallow painful, oval or round-shaped ulcer, smaller 
than 5mm in diameter. It affects the non-keratinized oral 
mucosa, especially vestibule, labial and oral mucosa, soft 
palate, tongue and tongue floor. The lesions heal within 
7 to 10 days. Recurrent Aphthoid Stomatitis Major (RASj) 
is the most severe form. Aphtha diameter can get bigger 
than 1cm, remaining in the oral cavity for a period longer 
than two weeks, often times leaving a scar. The third form 
of the disease, and the less common one is Herpetiform 
Recurrent Aphthoid Stomatitis (HRAS), characterized by 
multiple and painful 1 to 3mm ulcers, which may coalesce, 
forming larger and irregular lesions5.
Family history seems to be relevant in the genesis of 
RAS, and reports of cases in the same family are found in 
24% to 46% of the times6,7. Moreover, patients with family 
history of RAS can develop ulcers earlier on and have more 
severe manifestations than those without family history8. 
Monozygotic twins have a greater likelihood of suffering 
the disease when compared to dizygotic twins9.
Numerous associations and non-associations of 
HLA and RAS antigen have been reported in the medical 
literature. The association between the disease and HLA-
B12 was described by Lehner et al.10 and Malmström et 
al.11, however it was not confirmed by other authors12,13. In 
groups of patients of different ethnical origin, a significant 
association between HLA-DR2 and RAS was noticed10,14.
RAS pathophysiology seems to be associated with 
a disorder in immunomodulation15. Lymphocytes seem to 
be the predominant cells in aphthoid lesions, and there 
was a variation in the CD4+/CD8+ ratio during its diffe-
rent stages - prodrome or pre-ulceration, ulceration and 
healing16,17,18.
The main role played by the major histocompatibi-
lity complex in humans, called HLA system is to present 
processed peptides for recognition by the T-cell receptor 
in the different immunological functions. Since such re-
cognition is made at the same time involving the peptide 
and the HLA molecule, small variations in one of the two 
components cause immunologic recognition and the trig-
gering of cell activation and a specific response19. It is so 
understood because the HLA molecules are directly impli-
cated in the genetic control of the immune response.
We do not know of any Brazilian study that as-
sociates HLA type with RAS. Having said that, the goal 
of the present investigation was to typify classes I and II 
of HLA molecules from Brazilian patients with RAS and 
compare with the control group made up of 964 healthy 
Brazilians.
MATERIALS AND METHODS
 
Material
This is a prospective, cross-sectional, investigative 
study, carried out from February of 2004 through May of 
2006. It was approved by the Ethics in Research Commit-
tee of the University of São Paulo Medical School, under 
protocol # 876/04.
 
Study Group
The study group was initially made up of 58 patients 
with diagnostic suspicion of RAS, seen at the Stomatology 
Division of the ETN Clinic of the University of São Paulo 
Medical School Hospital.
 
Control Group
The control group was made up by a selection of 
4172 healthy Brazilian volunteers, members of the bone 
marrow donors data bank of the Transplant Center of the 
University of São Paulo Medical School Hospital.
From these, we selected only one member of each 
family, in order to avoid the presence of haplotypes, at the 
end making up a total of 962 Brazilian individuals.
 
Method
The patients were submitted to an interview, general 
physical exam, complete otorhinolaryngological exam, 
and a previous workup protocol, besides biopsies of the 
lesion and adjacent mucosa.
The prior workup protocol involved fast glucose, 
protein electrophoresis, CBC, coagulogram (TP + TT + 
TTPA), anti-HIV 1 and 2, dosage of total complement and 
fractions, rheumatoid factor, antinucleus factors, serum 
dosage of IgA, IgG, IgM, VHS, C-Reactive protein and 
serology for syphilis.
In order to rule out the etiology of ulcers associated 
with other diseases, such as pemphigoid lesions, Behcet’s 
disease, Crohn’s disease or vasculitis of other nature, all 
the patients were submitted to lesion biopsy for later his-
topathology test and direct immunofluorescence test. 
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Biopsy was carried out under 2% xylocaine injection 
without vasoconstrictor, by means of a puncher the size of 
the lesion (4-5mm). Two samples were taken; one with the 
lesion and one with the healthy adjacent area, the former 
was placed in a flask with 10% formaldehyde and sent to 
histopathological exam. The second sample was placed on 
gauze soaked in saline solution and immediately referred 
to the Skin Immunology Division of the Department of 
Dermatology for direct immunofluorescence.
 
Inclusion and Exclusion Criteria
In the study we included all those patients who 
reported at least on episode of aphtha (s) per month for a 
minimum period of one year, as well as those who signed 
the informed consent form agreeing with the procedures 
employed.
We excluded those patients who had alterations 
in the serum exam or those whom in the histopathology 
and direct immunofluorescence study had alterations that 
characterize other diseases. These patients were referred 
to specific treatment of the alterations found.
In order to obtain DNA, we collected 10ml of total 
peripheral blood in an EDTA 25mM flask. DNA extractions 
were carried out by the Hexadecyltrimethylammonium 
Bromide/dodecyltrimethylammonium Bromide (DTAB/
CTAB) test and HLA class I and II types by chain polyme-
rization - specific oligonucleotide sequence (PCR-SSO). 
The analysis was carried out in the Heart Institute of the 
University of São Paulo Medical School Hospital (Incor - 
FMUSP).
Blood collection, DNA extraction and HLA typing 
of both classes from the control group had already been 
carried out in this same lab.
 
Statistical Analysis
In order to check whether or not there was any as-
sociation between HLA antigens and their subgroups and 
RAS disease, we used the Chi-Squared test, and a given 
association was considered statistically significant when the 
test’s description level (p) were lower than 0.05 (or 5%). 
In order to estimate the power of the associations found, 
we calculated the relative risks (RR) and their respective 
confidence intervals of 95% (CI 95%).
The data was analyzed using the Statistical Package 
for Social Sciences (SPSS® for Windows 10.0; SPSS Inc, 
Chicago, Illinois, USA) software.
RESULTS
Of the 58 initial patients, 27 were taken off the study 
for numerous reasons. Of the remaining 31 patients, 17 
(54.84%) were women, 14 (45.16%) were men. Age varied 
between 7 and 70 years, reaching an average of 36.14 years 
and standard deviation of 15.33 (Table 1).
As to the types of aphthas the study patients had, 
there was a predominance of the minor type (67.74%). 
Please notice the absence of patients with herpetiform 
aphthas (Table 1).
Regarding the frequency type of Class I an II HLA 
antigens in the study group, Table 2 shows the frequency 
of each patient.
Table 3 shows the prevalences of HLA Class I anti-
gen in which there was a statistically significant difference 
between the study group (without considering the type 
of aphtha) and the control group. The relative risk (RR) 
of patients with RAS who had HLA frequencies of A33, 
B35 and B81 was of 3.48 (CI95% 1.38 - 8.8; p = 0.016); 
3.48 (CI95% 1.69 - 7.16; p < 0.001) and 8.22 (CI95% 1.67 
- 40.41; p = 0.036), respectively, times the control group.
Class II HLA frequencies of the study group whi-
ch had greater index were Dr7, present in 10 patients 
(16.13%), Dr11 and Dr 17, the latter two were present in 
eight patients (12.90%). When compared to the control 
group, there was no statistically significant difference.
When RAS patients were broken down according 
to the type of aphtha, the prevalence of HLA A33 and 
Table 1. Demographic data from the 31 patients with RAS according to the type of RAS presented.
Aphtha type
Minor Major Herpetiform p Total
(n = 21) (n = 10) (n = 0) (n = 31)
(67,74 %) (32,26 %) (0,00 %) (100,00 %)
Gender
Male 10 (47,6 %) 4 (40,0 %) 0 (0,0 %) 1,0 14 (45,2 %)
Female 11 (52,4 %) 6 (60,0 %) 0 (0,0 %) 17 (54,8 %)
Age (years) 35,6 ± 14,5 37,2 ± 17,5 - 0,79 36,1 ± 15,2
< 20 2 (9,5 %) 2 (20,0 %) 0,35 4 (12,9 %)
20 a 39 12 (57,1 %) 3 (30,0 %) 15 (48,4 %)
≥ 40 7 (33,3 %) 5 (50,0 %) 12 (38,7 %)
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B35 frequencies in the group with aphtha minor remai-
ned higher than those from the control group, in a sta-
tistically significant way, with RR of 3.27 (1.1 - 9.4; p = 
0.047) and 4.73 (CI95% 2.0 - 11.1; p < 0.001), in relation 
to the control group, respectively, according to Table 4. 
Because of the reduction in the number of patients after 
the subdivision was made, the differences in HLA B81 
frequency prevalences between both groups of aphtha 
and control patients, and HLA A33 and B35 between the 
aphtha major and control groups have a greater likelihood 
(5%) of being by chance and, therefore, not statistically 
significant (p > 0.05).
Table 2. Distribution as to HLA class I and II frequency of 31 patients 
with RAS.
Patient  HLA-A HLA-B HLA-Dr
1 A1 A11 B35 B63 DR13 DR16
2 A23 A26 B50 B51 DR4 DR13
3 A24 A24 B35 B65 DR1 DR16
4 A25 A34 B7 B42 DR7 DR10
5 A33 A68 B65 B71 DR1 DR 17
6 A2 A2 B7 B61 DR10 DR11
7 A2 A32 B18 B35 DR4 DR16
8 A2 A66 B35 B58 DR13 DR17
9 A74 A74 B35 B81 DR9 DR14
10 A3 A29 B35 B44 DR8 DR7
11 A1 A24 B13 B56 DR1 DR15
12 A23 A80 B44 B72 DR4 DR7
13 A24 A33 B35 B49 DR7 DR15
14 A24 A29 B51 B64 DR7 DR11
15 A2 A23 B50 B51 DR7 DR11
16 A2 A30 B18 B39 DR14 DR17
17 A32 A66 B35 B58 DR4 DR11
18 A11 A11 B7 B35 DR15 DR103
19 A2 A24 B18 B35 DR8 DR17
20 A1 A2 B37 B50 DR7 DR103
21 A1 A3 B35 B57 DR11 DR17
22 A1 A23 B18 B81 DR7 DR11
23 A24 A31 B35 B51 DR11 DR13
24 A2 A29 B44 B64 DR7 DR17
25 A2 A3 B51 B62 DR13 DR16
26 A31 A33 B39 B65 DR1 DR8
27 A24 A30 B8 B35 DR11 DR17
28 A3 A33 B35 B49 DR7 DR7
29 A11 A33 B13 B35 DR15 DR15
30 A2 A33 B41 B65 DR1 DR17
31 A2 A24 B18 B62 DR8 DR15
Table 3. Class I HLA antigen frequency in patients with Recurrent 
Aphthoid Stomatitis (RAS) compared to the control group.
Group
RAS 
(n = 31)
Control
(n = 961)
p
RR 
(CI 95%)
A33 6 (19,4 %) 62 (6,5 %) 0,016 3,48 (1,38 - 8,80)
B35 15 (48,4 %) 204 (21,2 %) < 0,001 3,48 (1,69 - 7,16)
B81 2 (6,5 %) 8 (0,8 %) 0,036 8,22 (1,67 - 40,41)
RR = Relative Risk; CI = Confidence Interval
Table 4. Class I HLA antigen frequency in patients with major and 
minor Recurrent Aphthoid Stomatitis compared to the Control 
Group.
Group
Aphtha 
Minor
(n = 21)
Controls 
(n = 961)
p RR (CI 95%)
A33 4 (19,0 %) 62 (6,5 %) 0,047 3,27 (1,1 - 9,4)
B35 12 (57,1 %) 204 (21,2 %) <0,001 4,73 (2,0 - 11,1)
B81 1 (4,8 %) 8 (0,8 %) 0,177 5,41 (0,8 - 36,1)
Group
Aphtha 
Major
(n = 10)
Controls 
(n = 961)
p RR (CI 95%
A33 2 (20,0 %) 62 (6,5 %) 0,137 3,54 (0,8 - 16,3)
B35 3 (30,0 %) 204 (21,2 %) 0,452 1,58 (0,4 - 6,1)
B81 1 (10,0 %) 8 (0,8 %) 0,089 11,88 (1,7 - 84,2)
RR = Relative Risk; CI = Confidence Interval
DISCUSSION
Recurrent aphthoid stomatitis is a common disease 
in the oral cavity and its etiology is still undefined20,3,7. It 
may be associated with local and systemic factors, its origin 
is immunological, microbiological and genetic21,22.
According to Jurge et al.4, the incidence of RAS is 
more common in the second decade of life, between 20 
and 30 years of age. In our study, the incidence was also 
higher in this same age range, with a total of eight patients 
(25.80%). Values very near this one, seven (22.5%), were 
obtained in the two following age ranges (30 to 40 years 
and 40 to 50 years).
Females had the higher RAS prevalence, 54.84%, 
when compared to males, 45.16%. These data are in 
agreement with the findings by Axéll and Henricsson23, 
but are also in conflict with those found by Miller et al.9, 
in which males had a higher prevalence.
In our study, the HLA frequencies that had the 
highest rates of patients with RAS were: HLA-A33, HLA-
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B35 and HLA-B81. When seen under the light of disease 
subtype, we found significant values for aphtha minor, in 
the frequencies of HLA-A33 and HLA-B35. For RAS Major, 
no frequency presented statistically significant value.
In an English population, Challacombe et al.18 found 
the HLA-B12 frequence associated with patients with RAS. 
When analyzed in relation to the subtypes of aphthoid Sto-
matitis the same B12 frequency was statistically significant 
only for herpetiform aphthas. For types Major and Minor, 
no prevalent frequency was found by the authors. In our 
study, because of its low incidence, it was not possible to 
find patients with the herpetiform type.
The same HLA-B12 frequency was found by Malms-
tröm et al.11 when they studied 14 Finish patients with RAS. 
Differently from our studies, these authors did not use a 
control group, and their RAS patient sample was small.
Gallina et al.12, with a sample of 26 Sicilian patients 
with RAS, found a statistically increased value for HLA-DR7 
frequency. As we make a critical analysis of the experi-
mental group selected, we notice that patients with only 
two episodes per year were considered RAS patients, and 
such characteristic did not match the RAS clinical picture 
established by Stanley5 and Scully2, who characterized as 
RAS those monthly episodes of aphtha for at least one 
year, the same we did in our study.
Albanidou-Farmaki et al.14 did a study with 106 pa-
tients with RAS. The HLA-DR5 frequency, differently from 
our findings, was predominant in these patients. On the 
other hand, the HLA-DR4 frequency was reduced.
Sun et al.24 stated that the HLA-DRw9 frequency 
can be considered a genetic marker for RAS in the Chi-
nese population. Their study was made up of 80 Chinese 
patients with RAS. In this study, they typed the HLA-DR, 
differently from our study, in which we also typed the 
HLA-A and B.
In an Arab population, Jaber et al.25 studied 22 
patients with RAS, and observed a statistically significant 
increase in HLA-B52 and B44 molecules in patients with 
this disease when compared to the control group. The 
HLA-B51 frequency has been found in some papers asso-
ciated with RAS in countries like Israel and Korea26,27.
It is important to stress that with the progress in HLA 
typing methodology, the serum method is no longer used, 
in which it was necessary to have specific ligants (antibo-
dies) in order to show the presence of the corresponding 
HLA frequence, as used by some authors11,12,14,18,28,29. In our 
study, we used the cellular method, in which one uses the 
mixed lymphocitic reactions, making the HLA typing more 
reliable, allowing the discovery of new frequencies30.
On the other hand, according to Braun Prado et al.31 
and Monte et al.32, the HLA-B35 frequency is extremely 
common in the general Brazilian population, and such 
fact was also seen in our control group. Nonetheless, it is 
important to stress that although the HLA-B35 frequency 
was also found high in our experimental group; such fact 
did not happen by chance, there was a statistically sig-
nificant difference in the incidence of this gene between 
the two groups.
We must also remember that, as mentioned by 
Louzada-Junior et al.33 the reduced frequency of HLA 
typing could be a protection factor for RAS. In our study 
we did not notice any of such events.
Finally, the fact that many papers found HLA fre-
quencies for RAS different from the ones found in our 
study, probably happened because the populations studied 
were from different nationalities (Danish, Scottish, Israelis, 
Chinese, Koreans) and ethnic origins different from ours, 
a highly mixed races country.
Our findings show that the HLA frequencies must 
be done specifically for each population, so that we can 
map the possible genetic factors involved in the genesis 
of this disorder.
We have to stress in our study that the lack of pa-
tients with herpetiform recurrent aphthoid stomatitis and 
the low number of patients with stomatitis type major, 
prevented a more accurate assessment of the HLA fre-
quencies associated with these disease forms.
At any rate, the relatively reduced series of patients 
with RAS in our study does not invalidate our results, ha-
ving seen that the HLA frequencies found in our patients 
were very different from those obtained from the control 
group of patients without RAS.
CONCLUSION
The results from our study suggest that minor RAS 
is associated with the HLA-A33 and HLA-B35 frequencies 
in the Brazilian population.
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